Literature DB >> 22573295

Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer.

A Fiorentino1, R Caivano, V Metallo, C Chiumento, M Cozzolino, G Califano, S Clemente, P Pedicini, V Fusco.   

Abstract

OBJECTIVE: To evaluate volumetric changes of parotid glands (PGs) during intensity-modulated radiotherapy (IMRT) in head and neck cancer patients.
METHODS: During IMRT all patients underwent kilovolt cone-beam CT (CBCT) scans to verify the set-up positioning in a protocol study. On each CBCT scan, the PGs were retrospectively contoured and evaluated with a dose-volume histogram.
RESULTS: From February to June 2011, 10 patients were enrolled. 140 CBCT scans were registered (280 PGs): for each patient, a median of 14 CBCT scans were performed (range 14-16). At the start of radiation, the average volume for ipsilateral PGs (iPGs) was 18.77 ml (range 12.9-31.2 ml), whereas for contralateral PGs (cPGs) it was 16.63 ml (range 8.3-28.7 ml). At the last CBCT scan, the average volume loss was 43.5% and 44.0% for the iPG and cPG, respectively. When we analysed the percentage of volume loss, we observed that the volume decreased by linear regression (r(2)=0.92 for iPG; r(2)=0.91 for cPG), with an average volume loss rate of 1.5% per day for both PGs. During the third week of treatment the volume of both PGs reduced by 24-30%.
CONCLUSION: Our data show that, during IMRT, the shrinkage of PGs should be taken into account. A replan could be indicated in the third week of radiotherapy.

Entities:  

Mesh:

Year:  2012        PMID: 22573295      PMCID: PMC3474039          DOI: 10.1259/bjr/30678306

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  25 in total

Review 1.  Intensity-modulated radiotherapy: current status and issues of interest.

Authors: 
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-15       Impact factor: 7.038

2.  Tumour shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treated on the TomoTherapy HiArt™ system.

Authors:  H Loo; J Fairfoul; A Chakrabarti; J C Dean; R J Benson; S J Jefferies; N G Burnet
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-10-06       Impact factor: 4.126

Review 3.  Innovations in image-guided radiotherapy.

Authors:  Dirk Verellen; Mark De Ridder; Nadine Linthout; Koen Tournel; Guy Soete; Guy Storme
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

Review 4.  New advances in high-technology radiotherapy for head and neck cancer.

Authors:  Gregory J Kubicek; Mitchell Machtay
Journal:  Hematol Oncol Clin North Am       Date:  2008-12       Impact factor: 3.722

5.  Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: is the gain in dose distribution worth the effort?

Authors:  Pierre Castadot; Xavier Geets; John Aldo Lee; Vincent Grégoire
Journal:  Radiother Oncol       Date:  2011-07-01       Impact factor: 6.280

6.  Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.

Authors:  Eric K Hansen; M Kara Bucci; Jeanne M Quivey; Vivian Weinberg; Ping Xia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-26       Impact factor: 7.038

7.  Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.

Authors:  Yasumasa Nishimura; Kiyoshi Nakamatsu; Toru Shibata; Shuichi Kanamori; Ryuta Koike; Masahiko Okumura; Minoru Suzuki
Journal:  Jpn J Clin Oncol       Date:  2005-06-23       Impact factor: 3.019

8.  Reducing radiation exposure to patients from kV-CBCT imaging.

Authors:  George X Ding; Peter Munro; Jason Pawlowski; Arnold Malcolm; Charles W Coffey
Journal:  Radiother Oncol       Date:  2010-09-16       Impact factor: 6.280

9.  Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration.

Authors:  Eliana M Vásquez Osorio; Mischa S Hoogeman; Abrahim Al-Mamgani; David N Teguh; Peter C Levendag; Ben J M Heijmen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-01       Impact factor: 7.038

10.  Impact of geometric uncertainties on dose distribution during intensity modulated radiotherapy of head-and-neck cancer: the need for a planning target volume and a planning organ-at-risk volume.

Authors:  O Ballivy; W Parker; T Vuong; G Shenouda; H Patrocinio
Journal:  Curr Oncol       Date:  2006-06       Impact factor: 3.677

View more
  17 in total

1.  Pattern and predictors of volumetric change of parotid glands during intensity modulated radiotherapy.

Authors:  G Sanguineti; F Ricchetti; O Thomas; B Wu; T McNutt
Journal:  Br J Radiol       Date:  2013-09-12       Impact factor: 3.039

2.  Organ sparing and clinical outcome with step-and-shoot IMRT for head and neck cancer: a mono-institutional experience.

Authors:  Rosario Mazzola; Giuseppe Ferrera; Filippo Alongi; Mariella Mannino; Boris Abbate; Teresa Cucchiara; Giuseppina Iacoviello; Francesco Sciumè; Gioacchino Di Paola; Manuela Federico; Livio Blasi; Antonio Lo Casto; Roberto Lagalla; Domenico Messana
Journal:  Radiol Med       Date:  2015-02-07       Impact factor: 3.469

3.  Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia.

Authors:  Maria Luisa Belli; Elisa Scalco; Giuseppe Sanguineti; Claudio Fiorino; Sara Broggi; Nicola Dinapoli; Francesco Ricchetti; Vincenzo Valentini; Giovanna Rizzo; Giovanni Mauro Cattaneo
Journal:  Strahlenther Onkol       Date:  2014-04-23       Impact factor: 3.621

4.  Cone-beam computed tomography in lung stereotactic ablative radiation therapy: predictive parameters of early response.

Authors:  Rosario Mazzola; Alba Fiorentino; Francesco Ricchetti; Niccolò Giaj Levra; Sergio Fersino; Gioacchino Di Paola; Antonio Lo Casto; Ruggero Ruggieri; Filippo Alongi
Journal:  Br J Radiol       Date:  2016-06-01       Impact factor: 3.039

5.  Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment.

Authors:  R Mazzola; F Ricchetti; A Fiorentino; S Fersino; N Giaj Levra; S Naccarato; G Sicignano; S Albanese; G Di Paola; D Alterio; R Ruggieri; F Alongi
Journal:  Br J Radiol       Date:  2014-10-28       Impact factor: 3.039

Review 6.  Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO).

Authors:  Paola Franzone; Alba Fiorentino; Salvina Barra; Domenico Cante; Laura Masini; Elena Cazzulo; Liana Todisco; Pietro Gabriele; Elisabetta Garibaldi; Anna Merlotti; Maria Grazia Ruo Redda; Filippo Alongi; Renzo Corvò
Journal:  Radiol Med       Date:  2016-09-06       Impact factor: 3.469

7.  Head and neck intensity modulated radiotherapy parotid glands: time of re-planning.

Authors:  Alba Fiorentino; Mariella Cozzolino; Rocchina Caivano; Piernicola Pedicini; Caterina Oliviero; Costanza Chiumento; Stefania Clemente; Vincenzo Fusco
Journal:  Radiol Med       Date:  2013-12-12       Impact factor: 3.469

8.  Cone-beam computed tomography dose monitoring during intensity-modulated radiotherapy in head and neck cancer: parotid glands.

Authors:  A Fiorentino; M Cozzolino; R Caivano; P Pedicini; C Chiumento; C Oliviero; S Clemente; V Fusco
Journal:  Clin Transl Oncol       Date:  2012-10-13       Impact factor: 3.405

9.  Intimal-medial thickness and carotid arteries lumen in irradiated patients for head and neck cancer: preliminary data of an observational study.

Authors:  M Faruolo; A Fiorentino; G Gallucci; L Lapadula; V Fusco
Journal:  Clin Transl Oncol       Date:  2013-03-06       Impact factor: 3.405

10.  Evaluation of Conformity and Homogeneity Indices Consistency Throughout the Course of Head and Neck Cancer Treatment With and Without Using Adaptive Volumetric Modulated Arc Radiation Therapy.

Authors:  Salam Abdulrazzaq Ibrahim Al-Rawi; Hassan Abouelenein; Magdy Mohammed Khalil; Haidar Hamza Alabdei; Awf Abdulrahman Sulaiman; Dalya Saad Al-Nuaimi; Mohamed El-Sayed El Nagdy
Journal:  Adv Radiat Oncol       Date:  2022-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.